The notices it replaced
16 notices, oldest first, each with its awards since FY2014.
- Year not statedRFA-CA-05-003None since FY2014
- Year not statedRFA-CA-06-003None since FY2014
- Year not statedRFA-CA-07-002None since FY2014
- Year not statedRFA-CA-07-018None since FY2014
- Year not statedRFA-CA-07-036None since FY2014
- Year not statedRFA-CA-08-008None since FY2014
- Posted 2008RFA-CA-09-007None since FY2014
- Posted 2009RFA-CA-10-004None since FY2014
- Posted 2011RFA-CA-12-003None since FY2014
- Posted 2012RFA-CA-13-0026 awards
- Posted 2013RFA-CA-14-00412 awards
- Posted 2015RFA-CA-15-00315 awards
- Posted 2015RFA-CA-16-00212 awards
- Posted 2016RFA-CA-17-01110 awards
- Posted 2017RFA-CA-18-00311 awards
- Posted 2019RFA-CA-19-02011 awards
- Posted 2019RFA-CA-20-018This notice, closed · 10 awards
Replaced by RFA-CA-21-004.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 87
- 87 new
- Median first-year cost
- $391,113
- $38,631,655 in all
- Institutions
- 59
- 80 contact PIs
- Patents
- 35
- from 20 funded projects
Awards by fiscal year
6
12
15
12
10
11
11
10
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- YALE UNIVERSITY5
- UNIVERSITY OF WASHINGTON4
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS3
- CORNELL UNIVERSITY3
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY3
and 54 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 TCRB-D (O1))11
- Special Emphasis Panel (ZCA1 TCRB-J (M1))10
- Special Emphasis Panel (ZCA1 TCRB-Q (O2))10
- Special Emphasis Panel (ZCA1 TCRB-J (J1))8
- Special Emphasis Panel (ZCA1 TCRB-9 (M1))7
and 12 other study sections
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2021 | Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy1R33CA256112-01A1 | Wei, Wei | INSTITUTE FOR SYSTEMS BIOLOGY, WA | First-year cost $462,881 | Study section ZCA1 |
| FY2021 | Joint receptor and protein expression immunophenotyping through split-pool barcoding1R33CA255893-01 | Seelig, Georg | UNIVERSITY OF WASHINGTON, WA | First-year cost $427,567 | Study section ZCA1 |
| FY2021 | Universal Sample Multiplexing for Single Cell Analysis1R33CA247744-01A1 | Gartner, Zev Jordan | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $398,629 | Study section ZCA1 |
| FY2021 | Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy1R33CA261726-01 | Cheng, Ji-Xin | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | First-year cost $398,440 | Study section ZCA1 |
| FY2021 | A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells1R33CA256086-01A1 | Brock, AmyJiang, Ning Jenny | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $394,894 | Study section ZCA1 |
| FY2021 | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics1R33CA258016-01 | Liu, Xuefeng | OHIO STATE UNIVERSITY, OH | First-year cost $390,660 | Study section ZCA1 |
| FY2021 | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer1R33CA257878-01 | Hansen, Anders Sejr | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | First-year cost $379,981 | Study section ZCA1 |
| FY2021 | Multimodal iterative sequencing of cancer genomes and single tumor cells1R33CA247700-01A1 | Ji, Hanlee P | STANFORD UNIVERSITY, CA | First-year cost $365,977 | Study section ZCA1 |
| FY2021 | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens1R33CA256102-01 | Greenberg, JoelKapadia, Anuj J. | DUKE UNIVERSITY, NC | First-year cost $360,935 | Study section ZCA1 |
| FY2021 | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles1R33CA252158-01A1 | Xu, LiangZeng, Yong | UNIVERSITY OF FLORIDA, FL | First-year cost $354,506 | Study section ZCA1 |
| FY2020 | T-cell Biofactories for targeting extracellular matrix1R33CA247739-01 · under RFA-CA-19-020 | Bhatnagar, Parijat | SRI INTERNATIONAL, CA | First-year cost $1,606,207 | Study section ZCA1 |
| FY2020 | Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer1R33CA236681-01A1 · under RFA-CA-19-020 | Verhaak, Roel GwWei, Chia-Lin | JACKSON LABORATORY, ME | First-year cost $1,377,810 | Study section ZCA1 |
| FY2020 | Comprehensive breakpoint analyses for simultaneous quantification of all DNA double strand break repair pathways1R33CA236670-01A1 · under RFA-CA-19-020 | Higginson, Daniel | SLOAN-KETTERING INST CAN RESEARCH, NY | First-year cost $1,322,190 | Study section ZCA1 |
| FY2020 | Multiplexed imaging of chromatin folding and RNA profiles in cancer1R33CA251037-01 · under RFA-CA-19-020 | Muzumdar, Mandar DeepakWang, Siyuan | YALE UNIVERSITY, CT | First-year cost $1,237,899 | Study section ZCA1 |
| FY2020 | Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores1R33CA246448-01A1 · under RFA-CA-19-020 | Hall, Adam Roger | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | First-year cost $1,089,730 | Study section ZCA1 |
| FY2020 | High-Throughput Screening Platform for Cancer Drug Discovery1R33CA240191-01A1 · under RFA-CA-19-020 | Recht, Michael | PALO ALTO RESEARCH CENTER, CA | First-year cost $720,575 | Study section ZCA1 |
| FY2020 | Clinical implementations of spatial transcriptomics in tumors1R33CA246455-01 · under RFA-CA-19-020 | Ashenberg, OrrChen, FeiRodig, Scott J | BROAD INSTITUTE, INC., MA | First-year cost $449,518 | Study section ZCA1 |
| FY2020 | High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer1R33CA246711-01 · under RFA-CA-19-020 | Fan, RongLu, Jun | YALE UNIVERSITY, CT | First-year cost $417,077 | Study section ZCA1 |
| FY2020 | Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies1R33CA240181-01A1 · under RFA-CA-19-020 | Chaichana, Kaisorn LeeCooks, Robert GrahamQuinones-Hinojosa, Alfredo | PURDUE UNIVERSITY, IN | First-year cost $392,146 | Study section ZCA1 |
| FY2020 | A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics1R33CA235294-01A1 · under RFA-CA-19-020 | Wang, Shaopeng | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | First-year cost $391,113 | Study section ZCA1 |
| FY2020 | Time-resolved FRET-based allostery sensors for any protein kinase drug target1R33CA246363-01 · under RFA-CA-19-020 | Levinson, Nicholas Mark | UNIVERSITY OF MINNESOTA, MN | First-year cost $375,535 | Study section ZCA1 |
| FY2019 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery1R33CA225549-01A1 · under RFA-CA-18-003 | Luker, Gary DTavana, Hossein | UNIVERSITY OF AKRON, OH | First-year cost $476,844 | Study section ZCA1 |
| FY2019 | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells1R33CA229042-01A1 · under RFA-CA-18-003 | Schneck, Jonathan P | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $416,450 | Study section ZCA1 |
| FY2019 | GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models1R33CA236687-01 · under RFA-CA-18-003 | Breunig, Joshua John | CEDARS-SINAI MEDICAL CENTER, CA | First-year cost $413,100 | Study section ZCA1 |
| FY2019 | Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation1R33CA229068-01A1 · under RFA-CA-18-003 | Schiavinato Eberlin, Livia | UNIVERSITY OF TEXAS AT AUSTIN, TX | First-year cost $411,941 | Study section ZCA1 |
| FY2019 | Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment1R33CA235319-01A1 · under RFA-CA-18-003 | Yang, Jenny J. | GEORGIA STATE UNIVERSITY, GA | First-year cost $407,268 | Study section ZCA1 |
| FY2019 | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers1R33CA225498-01A1 · under RFA-CA-18-003 | Chen, Sidi | YALE UNIVERSITY, CT | First-year cost $407,025 | Study section ZCA1 |
| FY2019 | Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics1R33CA225458-01A1 · under RFA-CA-18-003 | Gerber, Scott A.Kettenbach, Arminja Nadine | DARTMOUTH COLLEGE, NH | First-year cost $400,114 | Study section ZCA1 |
| FY2019 | Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer research1R33CA240201-01 · under RFA-CA-18-003 | Van Dam, Robert Michael | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $379,082 | Study section ZCA1 |
| FY2019 | Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer1R33CA235302-01A1 · under RFA-CA-18-003 | Brito, Ilana LaurenDe Vlaminck, IwijnZipfel, Warren R | CORNELL UNIVERSITY, NY | First-year cost $349,262 | Study section ZCA1 |
| FY2019 | Multiscale microscope for 3D cancer imaging in model organisms and organoids1R33CA235254-01 · under RFA-CA-18-003 | Fiolka, Reto Paul | UT SOUTHWESTERN MEDICAL CENTER, TX | First-year cost $328,541 | Study section ZCA1 |
| FY2019 | Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia1R33CA235597-01A1 · under RFA-CA-18-003 | August, KeithSoper, Steven Allan | UNIVERSITY OF KANSAS LAWRENCE, KS | First-year cost $241,587 | Study section ZCA1 |
| FY2018 | Pro-Codes: A novel vector and cell barcoding technology1R33CA223947-01A1 · under RFA-CA-17-011 | Brown, Brian D | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $421,587 | Study section ZCA1 |
| FY2018 | Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform1R33CA223908-01 · under RFA-CA-17-011 | Evens, Andrew MHuang, Tony JunKonry, Tania Tali | NORTHEASTERN UNIVERSITY, MA | First-year cost $421,501 | Study section ZCA1 |
| FY2018 | Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors1R33CA223904-01 · under RFA-CA-17-011 | Cima, Michael J | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | First-year cost $416,667 | Study section ZCA1 |
| FY2018 | An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer1R33CA225539-01 · under RFA-CA-17-011 | Jiang, Ning Jenny | UNIVERSITY OF TEXAS AT AUSTIN, TX | First-year cost $396,959 | Study section ZCA1 |
| FY2018 | CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer1R33CA225863-01 · under RFA-CA-17-011 | Lu, Jun | YALE UNIVERSITY, CT | First-year cost $395,674 | Study section ZCA1 |
| FY2018 | Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level1R33CA223581-01A1 · under RFA-CA-17-011 | Cheng, Ji-Xin | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | First-year cost $390,880 | Study section ZCA1 |
| FY2018 | Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations1R33CA229023-01 · under RFA-CA-17-011 | Tewari, MuneeshWalter, Nils G | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $388,440 | Study section ZCA1 |
| FY2018 | Multiplex matrix ELISA for T cell protein-interaction networks in cancer1R33CA228979-01 · under RFA-CA-17-011 | Schrum, Adam G. | UNIVERSITY OF MISSOURI-COLUMBIA, MO | First-year cost $387,880 | Study section ZCA1 |
| FY2018 | Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods1R33CA222344-01 · under RFA-CA-17-011 | Salipante, Stephen J | UNIVERSITY OF WASHINGTON, WA | First-year cost $386,677 | Study section ZCA1 |
| FY2018 | High-throughput super-resolution imaging of chromatin structures at different epigenetic states1R33CA225494-01 · under RFA-CA-17-011 | Liu, Yang | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $351,864 | Study section ZCA1 |
| FY2017 | Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes1R33CA217652-01 · under RFA-CA-16-002 | Makrigiorgos, G. Mike | DANA-FARBER CANCER INST, MA | First-year cost $456,746 | Study section ZCA1 |
| FY2017 | Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry1R33CA212973-01 · under RFA-CA-16-002 | Yates Iii, John R | SCRIPPS RESEARCH INSTITUTE, THE, CA | First-year cost $435,649 | Study section ZCA1 |
| FY2017 | Droplet microfluidic technology for single cell cancer genomics1R33CA212697-01 · under RFA-CA-16-002 | Klein, Allon Moshe | HARVARD MEDICAL SCHOOL, MA | First-year cost $411,954 | Study section ZCA1 |
| FY2017 | High Resolution High Throughput Proteomics Platform for Cancer Research1R33CA217699-01 · under RFA-CA-16-002 | Ibrahim, Yehia | BATTELLE PACIFIC NORTHWEST LABORATORIES, WA | First-year cost $410,858 | Study section ZCA1 |
| FY2017 | Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer1R33CA214333-01 · under RFA-CA-16-002 | Godwin, Andrew K.Samuel, GlensonZeng, Yong | UNIVERSITY OF KANSAS LAWRENCE, KS | First-year cost $400,098 | Study section ZCA1 |
| FY2017 | Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples1R33CA214176-01 · under RFA-CA-16-002 | Lu, Chang | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | First-year cost $391,723 | Study section ZCA1 |
| FY2017 | TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES1R33CA217700-01 · under RFA-CA-16-002 | Duncavage, Eric JWalter, Matthew J | WASHINGTON UNIVERSITY, MO | First-year cost $379,725 | Study section ZCA1 |
| FY2017 | Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells1R33CA204704-01A1 · under RFA-CA-16-002 | Wang, Yingxiao | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $376,821 | Study section ZCA1 |
| FY2017 | Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy1R33CA202881-01A1 · under RFA-CA-16-002 | Levenson, Richard M. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | First-year cost $373,637 | Study section ZCA1 |
| FY2017 | LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics1R33CA212968-01 · under RFA-CA-16-002 | Singh, Ankur | CORNELL UNIVERSITY, NY | First-year cost $371,216 | Study section ZCA1 |
| FY2017 | Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity1R33CA217780-01 · under RFA-CA-16-002 | Parker, Laurie L. | UNIVERSITY OF MINNESOTA, MN | First-year cost $345,244 | Study section ZCA1 |
| FY2017 | Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis1R33CA204574-01A1 · under RFA-CA-16-002 | Kelley, Shana O | UNIVERSITY OF TORONTO, ON | First-year cost $258,952 | Study section ZCA1 |
| FY2016 | Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology1R33CA206949-01 · under RFA-CA-15-003 | Spicer, Timothy Patrick | SCRIPPS FLORIDA, FL | First-year cost $501,426 | Study section ZCA1 |
| FY2016 | Clinical implementation of single cell tumor transcriptome analysis1R33CA202820-01 · under RFA-CA-15-003 | Regev, Aviv | BROAD INSTITUTE, INC., MA | First-year cost $457,465 | Study section ZCA1 |
| FY2016 | Analysis of scant cancer cells in fine needle aspirates1R33CA202064-01 · under RFA-CA-15-003 | Weissleder, Md, Phd, Ralph | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $433,261 | Study section ZCA1 |
| FY2016 | A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers1R33CA202900-01 · under RFA-CA-15-003 | Breunig, Joshua John | CEDARS-SINAI MEDICAL CENTER, CA | First-year cost $418,128 | Study section ZCA1 |
| FY2016 | Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma1R33CA196470-01A1 · under RFA-CA-15-003 | Lin, Qiao | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | First-year cost $394,518 | Study section ZCA1 |
| FY2016 | Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology1R33CA196458-01A1 · under RFA-CA-15-003 | Bhargava, RohitCheville, John C | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | First-year cost $387,693 | Study section ZCA1 |
| FY2016 | Charge sensitive optical detection for high-throughput study of small molecules1R33CA202834-01A1 · under RFA-CA-15-003 | Tao, Nongjian | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | First-year cost $381,382 | Study section ZCA1 |
| FY2016 | Online Raman Diagnostics of Oncometabolites1R33CA206922-01 · under RFA-CA-15-003 | Schultz, Zachary | UNIVERSITY OF NOTRE DAME, IN | First-year cost $363,875 | Study section ZCA1 |
| FY2016 | GESI: a novel technology for functional imaging in living cells1R33CA196445-01A1 · under RFA-CA-15-003 | Lam, Kit S | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | First-year cost $362,749 | Study section ZCA1 |
| FY2016 | Protein painting identifies therapeutic targets at protein-protein interfaces1R33CA206937-01 · under RFA-CA-15-003 | Liotta, Lance Allen | GEORGE MASON UNIVERSITY, VA | First-year cost $348,203 | Study section ZCA1 |
| FY2016 | High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing1R33CA202867-01 · under RFA-CA-15-003 | Nagrath, SunithaRamnath, Nithya | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $343,664 | Study section ZCA1 |
| FY2016 | A novel molecular assay for early detection and assessment of cancer risk1R33CA202898-01 · under RFA-CA-15-003 | Queimado, Lurdes | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | First-year cost $340,594 | Study section ZCA1 |
| FY2016 | Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors1R33CA206955-01 · under RFA-CA-15-003 | Weiss, Gregory A. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | First-year cost $322,131 | Study section ZCA1 |
| FY2016 | Large-Scale Integration of Single Cell RNA-Seq and High-Content Imaging for Analyzing Drug Response in Cancer1R33CA202827-01 · under RFA-CA-15-003 | Sims, Peter Alan | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $316,149 | Study section ZCA1 |
| FY2016 | Brillouin confocal microscopy for biomechanical studies of metastatic cascade in 3D microenvironments1R33CA204582-01 · under RFA-CA-15-003 | Scarcelli, Giuliano | UNIV OF MARYLAND, COLLEGE PARK, MD | First-year cost $295,733 | Study section ZCA1 |
| FY2015 | Single cell cytokine analysis of circulating malignant hematopoietic cells1R33CA196411-01 · under RFA-CA-14-004 | Fan, RongLevine, Ross L | YALE UNIVERSITY, CT | First-year cost $421,227 | Study section ZCA1 |
| FY2015 | High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis1R33CA182384-01A1 · under RFA-CA-14-004 | Burke, Peter J. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | First-year cost $412,541 | Study section ZCA1 |
| FY2015 | Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis1R33CA191245-01A1 · under RFA-CA-14-004 | Wu, Yun | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | First-year cost $411,504 | Study section ZCA1 |
| FY2015 | Development of a virion display (VirD) array to profile human GPCR interactions1R33CA186790-01A1 · under RFA-CA-14-004 | Desai, Prashant JZhu, Heng | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $403,372 | Study section ZCA1 |
| FY2015 | A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes1R33CA191198-01 · under RFA-CA-14-004 | Caron, Marc G. | DUKE UNIVERSITY, NC | First-year cost $389,963 | Study section ZCA1 |
| FY2015 | Using Adductomics to Characterize Exposures to Carcinogens1R33CA191159-01A1 · under RFA-CA-14-004 | Rappaport, Stephen Morris | UNIVERSITY OF CALIFORNIA BERKELEY, CA | First-year cost $380,395 | Study section ZCA1 |
| FY2015 | Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations1R33CA192980-01 · under RFA-CA-14-004 | Salipante, Stephen J | UNIVERSITY OF WASHINGTON, WA | First-year cost $375,858 | Study section ZCA1 |
| FY2015 | Scalable Cancer Genomics via Nanocoding and Sequencing1R33CA182360-01A1 · under RFA-CA-14-004 | Ma, JianSchwartz, David C. | UNIVERSITY OF WISCONSIN-MADISON, WI | First-year cost $372,503 | Study section ZCA1 |
| FY2015 | Fast interference-based super-resolution microscope for cancer mechanobiology1R33CA193043-01 · under RFA-CA-14-004 | Zipfel, Warren R | CORNELL UNIVERSITY, NY | First-year cost $364,273 | Study section ZCA1 |
| FY2015 | Single cell growth assay for residual cells in acute lymphoblastic leukemia1R33CA191143-01 · under RFA-CA-14-004 | Manalis, Scott R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | First-year cost $363,946 | Study section ZCA1 |
| FY2015 | RASL-Seq Expression Profiling of FFPE Tissues1R33CA183688-01A1 · under RFA-CA-14-004 | Yeakley, Joanne Mulligan | BIOSPYDER TECHNOLOGIES, INC., CA | First-year cost $363,706 | Study section ZCA1 |
| FY2015 | Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research1R33CA191110-01 · under RFA-CA-14-004 | Borges, Chad R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | First-year cost $317,654 | Study section ZCA1 |
| FY2014 | Integrating mass cytometric and transcriptomic profiles of solid tumors1R33CA183692-01 · under RFA-CA-13-002 | Weiss, William A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $408,712 | Study section ZCA1 |
| FY2014 | Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci1R33CA183659-01 · under RFA-CA-13-002 | Robinson, William H | STANFORD UNIVERSITY, CA | First-year cost $399,643 | Study section ZCA1 |
| FY2014 | Validation and Advanced Development of Duplex Sequencing1R33CA181771-01A1 · under RFA-CA-13-002 | Loeb, Lawrence A | UNIVERSITY OF WASHINGTON, WA | First-year cost $384,923 | Study section ZCA1 |
| FY2014 | Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics1R33CA177333-01A1 · under RFA-CA-13-002 | Federspiel, Mark J | MAYO CLINIC ROCHESTER, MN | First-year cost $375,008 | Study section ZCA1 |
| FY2014 | Non-Circulating Microparticles for Improved Localization and Resection Cancer1R33CA177449-01A1 · under RFA-CA-13-002 | Blair, Sarah L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $361,766 | Study section ZCA1 |
| FY2014 | Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp1R33CA183671-01 · under RFA-CA-13-002 | Parker, Laurie L. | UNIVERSITY OF MINNESOTA, MN | First-year cost $341,454 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Patents from its funded projects
35 patents name 20 of the 87 funded projects. The newest 5, by patent number.
- US 12,721,607 (opens the patent at USPTO, a PDF, in a new tab)COLLAPSIBLE FLUID COLLECTION SYSTEM FOR POINT-OF-CARE DIAGNOSTICSGranted September 1, 2026 to George Mason UniversityR33CA206937 · GEORGE MASON UNIVERSITY, VA
- US 12,710,262 (opens the patent at USPTO, a PDF, in a new tab)BOND-SELECTIVE FULL-FIELD OPTICAL COHERENCE TOMOGRAPHYGranted August 18, 2026 to Trustees of Boston UniversityR33CA261726 · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA
- US 12,702,696 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND COMPOSITION FOR MODULATING IMMUNE RESPONSE AND IMMUNE HOMEOSTASISGranted August 11, 2026 to Massachusetts Institute of Technology and President and Fellows of Harvard CollegeR33CA202820 · BROAD INSTITUTE, INC., MA
- US 12,697,398 (opens the patent at USPTO, a PDF, in a new tab)COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED IMMUNE-GENE THERAPYGranted August 4, 2026 to Yale UniversityR33CA225498 · YALE UNIVERSITY, CT
- US 12,693,295 (opens the patent at USPTO, a PDF, in a new tab)METHODS FOR INKJET PRINTING OBJECTS FOR MICROFLUIDIC DEVICESGranted July 28, 2026 to University of KansasR33CA214333 · UNIVERSITY OF KANSAS LAWRENCE, KS
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.